Nebulev-IL Inhaler
Levosalbutamol 50 mcg + Ipratropium 20 mcg MDI Inhaler
| Composition | Levosalbutamol 50 mcg + Ipratropium 20 mcg per dose |
|---|---|
| Dosage Form | MDI Inhaler |
| Pack Type | Aerosol Canister |
| Pack Size | 200 Metered Doses |
| MRP | ₹ 399 |
| Therapy | Pulmonology — SABA + SAMA Combination Inhaler |
| Storage | Store below 30 °C in a dry place, protected from light and moisture. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Nebulev-IL Inhaler
Nebulev-IL Inhaler delivers Levosalbutamol 50 mcg + Ipratropium 20 mcg as MDI inhaler — combination short-acting beta-2 agonist (SABA) + short-acting muscarinic antagonist (SAMA) for COPD maintenance and acute asthma exacerbations. The combined effect outperforms either agent alone.
Manufactured by Trumac Healthcare under WHO-GMP. Available for monopoly-based PCD pharma franchise and third-party manufacturing.
Indications
- COPD maintenance bronchodilation
- Acute asthma exacerbation (combined SABA+SAMA)
- Acute COPD exacerbation
- Bronchial reversibility testing
Mechanism of Action
Levosalbutamol (R-salbutamol enantiomer) is a selective beta-2 adrenergic agonist providing bronchodilation with less tachycardia than racemic salbutamol. Ipratropium is a short-acting muscarinic antagonist (SAMA) producing complementary bronchodilation by blocking parasympathetic bronchoconstriction. Combined provides faster and more sustained bronchodilation than either alone.
Dosage & Administration
Adults: 2 puffs 3–4 times daily.
Side Effects
Tachycardia, tremor, hypokalaemia, dry mouth (Ipratropium), nervousness.
Contraindications & Precautions
Hypersensitivity, severe cardiovascular disease, hyperthyroidism, narrow-angle glaucoma (Ipratropium).
Storage
Store below 30 °C in a dry place, protected from light and moisture.
Nebulev-IL Inhaler is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
What is Nebulev-IL Inhaler used for?
Nebulev-IL Inhaler contains Levosalbutamol 50 mcg + Ipratropium 20 mcg per dose. Used as per the indications described above.
How should Nebulev-IL Inhaler be taken?
As directed by your physician. Complete the prescribed course.
Is Nebulev-IL Inhaler available for PCD pharma franchise?
Yes, Trumac Healthcare offers Nebulev-IL Inhaler on monopoly-based PCD pharma franchise and for third-party manufacturing.
How should Nebulev-IL Inhaler be stored?
Store below 30 °C in a dry place, protected from light and moisture.
Is Nebulev-IL Inhaler WHO-GMP certified?
Yes, manufactured in WHO-GMP and DCGI-compliant facilities.
Related Products
- Nebulev-IL Respules (4x5x2.5ml) — Levosalbutamol + Ipratropium per 2.5 ml
- Nebulev-IL Respules (6x5x2.5ml) — Levosalbutamol + Ipratropium per 2.5 ml
- Nebulev-0.63 Respules — Levosalbutamol 0.63 mg per 2.5 ml